programma definitivo - Società italiana di neurologia
programma definitivo - Società italiana di neurologia
programma definitivo - Società italiana di neurologia
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
150. CEREBROSPINAL FLUID CXCL13 AS A PROGNOSTIC MARKER IN<br />
CLINICALLY ISOLATED SYNDROME PATIENTS<br />
D. FERRARO, L. FEDERZONI, V. GALLI, R. BEDIN, F. VITETTA, A. SIMONE, P. NICHELLI,<br />
P. SOLA (Modena)<br />
151. UNMET NEEDS OF PEOPLE WITH SEVERE MULTIPLE SCLEROSIS<br />
AND THEIR CARERS: QUALITATIVE DATA TO CONSTRUCT A HOME<br />
PALLIATIVE CARE PROGRAM<br />
A. SOLARI, C. BORREANI, E. BIANCHI, S. CILIA, M. GIUNTOLI, E. PIETROLONGO, I.<br />
ROSSI, M. GRASSO, F. PATTI, L. LOPES, A. LUGARESI, P. CONFALONIERI, P. MORINO,<br />
L. PALMISANO, G. MARTINO, M. PONZIO, R. AMADEO, P. ZARATIN, M. BATTAGLIA,<br />
A. GIORDANO, A. SOLARI ON BEHALF OF THEPENSAMI PROJECT (Milano, Catania,<br />
Genova, Chieti, Roma, Firenze)<br />
152. CEREBELLAR FUNCTIONAL CONNECTIVITY IN PATIENTS WITH<br />
PEDIATRIC MULTIPLE SCLEROSIS<br />
S. CIRILLO, M. ROCCA, P. VALSASINA, P. VEGGIOTTI, L. MOIOLA, A. GHEZZI, G. COMI,<br />
A. FALINI, M. FILIPPI (Milano, Pavia, Gallarate - VA)<br />
153. EFFECTS OF GLATIRAMER ACETATE ON CORTICAL FUNCTIONS<br />
AND FATIGUE IN MULTIPLE SCLEROSIS: A MORPHO-FUNCTIONAL<br />
MRI STUDY<br />
P. TORTORELLA, L. GRIFFANTI, F. BAGLIO, M. CABINIO, P. CECCONI, D. CAPUTO,<br />
M. ROVARIS (Milano)<br />
154. PREVALENCE OF AUTOIMMUNE THYROIDITIS IN AN ITALIAN MULTIPLE<br />
SCLEROSIS COHORT<br />
S. MONTELLA, I. CERILLO, G. CERULLO, M. PETRACCA, N. OREFICE, D. ARPAIA, B.<br />
BIONDI, G. OREFICE, P. CARRIERI (Napoli)<br />
155. PREVALENCE AND PROFILES OF COGNITIVE IMPAIRMENT IN PATIENTS<br />
WITH CLINICALLY ISOLATED SYNDROMES, RELAPSING AND<br />
PROGRESSIVE MULTIPLE SCLEROSIS<br />
E. PORTACCIO, B. GORETTI, B. HAKIKI, F. PATTI, S. CILIA, P. GALLO, P. GROSSI, R.<br />
VITERBO, A. GHEZZI, M. ROSCIO, F. MATTIOLI, C. STAMPATORI, M. TROJANO, M.<br />
AMATO (Firenze, Catania, Padova, Bari, Gallarate - VA, Brescia)<br />
156. “REBOUND” ACTIVITY AFTER NATALIZUMAB AND FINGOLIMOD<br />
TREATMENT INTERRUMPTION<br />
M. RADAELLI, L. MOIOLA, F. SANGALLI, V. BARCELLA, L. FERRÈ, M. RODEGHER, G.<br />
COMI, V. MARTINELLI (Milano)<br />
157. RITUXIMAB TREATMENT IN PATIENTS AFFECTED BY NEUROMYELITIS<br />
OPTICA SPECTRUM OF DISORDER: LONG TERM SAFETY AND EFFICACY<br />
IN CLINICAL PRACTICE<br />
M. RADAELLI, L. MOIOLA, M. RODEGHER, B. COLOMBO, R. FAZIO, F. SANGALLI, V.<br />
BARCELLA, L. FERRÈ, P. PREZIOSA, V. MARTINELLI, G. COMI (Milano)<br />
158. AN OBSERVATIONAL STUDY OF FINGOLIMOD TREATED RELAPSING<br />
MS PATIENTS: EARLY DATA ON SAFETY AND EFFICACY<br />
D. PAOLICELLI, A. MANNI, V. DIRENZO, M. D’ONGHIA, M. RUGGIERI, M. TROJANO<br />
(Bari)<br />
159. RELATION BETWEEN DISEASE DURATION, DISABILITY AND COGNITIVE<br />
IMPAIRMENT IN MULTIPLE SCLEROSIS<br />
G. FENU, E. COCCO, L. LOREFICE, M. MURGIA, C. SARDU, G. COGHE, J. FRAU, M.<br />
MELIS, L. MUSU, M. MARROSU (Cagliari)<br />
160. WII MAY IMPROVE PHYSICAL ABILITIES IN MULTIPLE SCLEROSIS: A<br />
RANDOMIZED SINGLE BLIND STUDY<br />
C. LEONE, V. CIMINO, V. DIBILIO, S. MESSINA, E. D’AMICO, C. CHISARI, A. RUSSO,<br />
D. VECA, F. ZAGARI, F. PATTI, M. ZAPPIA (Catania)<br />
3<br />
N<br />
O<br />
V<br />
E<br />
M<br />
B<br />
R<br />
E<br />
•<br />
A<br />
R<br />
E<br />
A<br />
P<br />
O<br />
S<br />
T<br />
E<br />
R<br />
139
Change language